Mashreq, one of the leading financial institutions in the MENA region, is set to announce a strategic partnership with Clari5, a global leader in real-time financial crime management, to launch Clari5 ...

Immunofoco, a company dedicated to advancing cell therapies for solid tumors, announced that its independently developed, innovative lentiviral vector-based In Vivo CAR-T Technology Platform made a ...

Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international exhibitions this May: EuroMedLab 2025 in Brussels, ...

The global ASEAN Point of Care Diagnostics Market, valued at US$1.05 billion in 2024, is forecasted to grow at a robust CAGR of 4.7%, reaching ...

The global ASEAN Point of Care Diagnostics Market, valued at US$1.05 billion in 2024, is forecasted to grow at a robust CAGR ...

Anbio Biotechnology’s NNNN share price has surged by 5.23%, which has investors questioning if this is right time to sell.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

As of April 29, 2025, Anbio Biotechnology had a $282.2 million market capitalization, putting it in the 36th percentile of companies in the Biotechnology industry. Currently, Anbio Biotechnology’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We've identified the following companies as similar to Anbio Biotechnology because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...

Biotech mogul Sam Waksal – who landed in prison two decades ago over the ImClone insider trading scandal that also resulted in jail time for Martha Stewart – allegedly tested an illegal ...